| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 24, 2015Offer Significantly Below Prior Proposal Based on Unaffected Mylan Stock Price
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO, TASE) today announced its rejection of the unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL) to acquire all of the outstanding...
-
Apr 22, 2015
Dublin, Ireland – April 22, 2015 – On April 16, Perrigo Company plc (NYSE: PRGO; TASE) announced it had received final U.S. Food and Drug Administration approval and had launched the...
-
Apr 21, 2015Company Provides Guidance for Calendar Year 2015 and Three-Year Organic Net Sales Growth Rate Goals
Third Quarter FY 2015 Highlights: Delivered record fiscal third quarter net sales of $1.05 billion. Excluding the effect of the pre-closing debt and equity issuances related to the Omega Pharma...
-
Apr 21, 2015This is an announcement falling under Rule 2.4 of Irish Takeover Panel Act, 1997, Takeover Rules, 2013 (the "Irish Takeover Rules").
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that its Board of Directors has unanimously rejected the unsolicited Proposal (the "Proposal") from Mylan NV ("Mylan") (NASDAQ:...
-
Apr 20, 2015
Thousands of law enforcement K-9s put their lives on the line to protect America on a daily basis. They are usually the first officer to enter a dangerous situation, and help track and neutralize...
-
Apr 16, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final Federal Drug Administration approval for Triamcinolone Acetonide Topical Aerosol, the generic version of Sun...
-
Apr 8, 2015This is an announcement falling under Rule 2.4 of Irish Takeover Panel Act, 1997, Takeover Rules, 2013 (the "Takeover Rules").
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO; TASE) notes the announcement made by Mylan NV ("Mylan") (NASDAQ: MYL). Perrigo confirms that it has received an unsolicited,...
-
Apr 8, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application for...
-
Mar 30, 2015- Advances Perrigo's stated strategy to expand internationally and leverage the combined product portfolio of Perrigo and Omega
Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that it has completed the acquisition of Belgian-based Omega Pharma...
-
Mar 4, 2015
Booth No. 2615 -- Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), showcased two new product lines at the 2015 Global Pet Expo: SENTRY® Fiproguard® Plus and SENTRY®...